Dr. Howard M. Schecht, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Toledo College of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 678
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: University of Toledo College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
OH license 35064069
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Promedica Toledo Hospital Toledo, OH
- Bay PArk Community Hospital Oregon, OH
- University of Toledo Medical Center Toledo, OH
- Wood County Hospital Bowling Green, OH
- Fostoria Community Hospital Fostoria, OH
Medical groups
- Toledo Clinic Incorporated (210 clinicians)
- Wood Health Company LLC (61 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 678
- Services billed
- 1,844
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in arm or leg muscles, complete study | 314 | 206 |
| Established patient office or other outpatient visit, 20-29 minutes | 283 | 252 |
| Established patient office or other outpatient visit, 30-39 minutes | 178 | 151 |
| Nerve conduction, 5-6 studies | 85 | 84 |
| New patient office or other outpatient visit, 45-59 minutes | 77 | 77 |
| Nerve conduction, 7-8 studies | 40 | 40 |
| Nerve conduction, 9-10 studies | 40 | 40 |
| Nerve conduction, 3-4 studies | 29 | 29 |
| Established patient office or other outpatient visit, 40-54 minutes | 27 | 26 |
| Nerve conduction, 11-12 studies | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Donepezil Hcl Other prescribers in Toledo, OH | 332 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Toledo, OH | 291 |
| Memantine Hcl Other prescribers in Toledo, OH | 239 |
| Levetiracetam Other prescribers in Toledo, OH | 193 |
| Gabapentin Other prescribers in Toledo, OH | 151 |
| Topiramate Other prescribers in Toledo, OH | 98 |
| Lacosamide Other prescribers in Toledo, OH | 80 |
| Citalopram Hbr (citalopram hydrobromide) Other prescribers in Toledo, OH | 78 |
| Lamotrigine Other prescribers in Toledo, OH | 77 |
| Primidone Other prescribers in Toledo, OH | 74 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 30 companies reported 268 payments worth $5,244 in total to this clinician.
| Mdd US Operations, LLC | $825 |
|---|---|
| AbbVie Inc. | $774 |
| EMD Serono, Inc. | $753 |
| Alexion Pharmaceuticals, Inc. | $307 |
| Genzyme Corporation | $253 |
| Csl Behring | $232 |
| Novartis Pharmaceuticals Corporation | $200 |
| Pfizer Inc. | $173 |
| Food and Beverage | $5,111 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $86.30 |
| Education | $46.84 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mdd US Operations, LLC Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) Apokyn · APOMORPHINE HYDROCHLORIDE | $45.03 |
| Mdd US Operations, LLC Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Apokyn · APOMORPHINE HYDROCHLORIDE | $23.18 |
| Csl Behring Apr 29, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring May 9, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring Jul 7, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Csl Behring Dec 11, 2025 | Education Hizentra · Immunology · in-kind | $11.71 |
| Mdd US Operations, LLC Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) Apokyn · APOMORPHINE HYDROCHLORIDE | $8.38 |
| Mdd US Operations, LLC Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) Apokyn · APOMORPHINE HYDROCHLORIDE | $7.82 |
| Mdd US Operations, LLC Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) Apokyn · APOMORPHINE HYDROCHLORIDE | $1.89 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,500 in research payments for these studies, mostly to the institutions running them.
- Observational evaluation of Effectiveness And Patient-Reported outcomes (PROs) in suboptimally controlled patients previously taking oral or infusion disease-modifying drugs (DMDs) for relapsing forms of multiple scle…
EMD Serono, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.